Risperdal Lawyers at Bernstein Liebhard LLP Note New Study Finding High Rate of Off-Label Antipsychotic Drug Use in U.K.

The Firm is currently representing numerous U.S. plaintiffs in Risperdal gynecomastia claims which allege the drug was often prescribed for unapproved, off-label uses.

(PRWeb January 06, 2015)

Read the full story at

Leave a reply